Actemra SC (tocilizumab SC) / Roche, Halozyme  >>  Phase 1
Welcome,         Profile    Billing    Logout  

9 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Actemra SC (tocilizumab SC) / Roche, Halozyme
ACTRN12621000663853: A single dose phase 1 study to evaluate safety and Pharmacokinetics of three tocilizumab products in normal healthy volunteers

Completed
1
300
 
Dr. Reddy’s Laboratories Ltd., Biologics, Dr. Reddy’s Laboratories Ltd., Biologics
Rheumatoid arthritis (RA), Giant Cell Arteritis (GCA)
 
 
NCT05188378: A Study to Compare the Pharmacokinetics and Safety of CT-P47 and RoActemra in Healthy Subjects

Recruiting
1
300
RoW
CT-P47, EU-approved RoActemra,
Celltrion
Healthy Subjects
10/22
01/23
NCT05968508: A Randomized, Double-blind, Single-dose, Two-arm Parallel Study to Compare the Pharmacokinetics and Safety of BAT1806 Prefilled Subcutaneous Injection With RoActemra® in Healthy Chinese Male Subjects

Active, not recruiting
1
300
RoW
BAT1806 prefilled subcutaneous injection/RoActemra® (from EU)
Bio-Thera Solutions
Healthy Men
12/24
04/25
NCT04885829: Comparative Study of 3 Tocilizumab Products in Normal Healthy Volunteeers

Completed
1
300
RoW
Tocilizumab Prefilled Syringe, Actemra, RoActemra
Syneos Health, Dr. Reddy's Laboratories Limited
Rheumatoid Arthritis, Giant Cell Arteritis
05/23
05/23
ISRCTN17975931: A study to evaluate the safety, tolerability, processing by the body, mechanism of action, and effectiveness of glofitamab following obinutuzumab pretreatment in patients with B-cell non-Hodgkin lymphoma

Recruiting
1
36
Australia, Belgium, Denmark, Italy, Poland, Spain, US
Gazyva (obinutuzumab) - Roche, Biogen, Nippon Shinyaku, Columvi (glofitamab) - Roche, dexamethasone - Generic mfg., Actemra IV (tocilizumab) - Roche, JW Pharma, Actemra SC (tocilizumab SC) - Roche, Halozyme
Genentech, Inc;Genentech, Genentech
B-cell non-Hodgkin lymphoma
 
 
NL-TCZ-12280, NCT06262477: A Study to Evaluate the Pharmacokinetics, Safety and Immunogenicity of BIIB800 Subcutaneously (SC) Compared to Actemra® in Healthy Male Participants

Recruiting
1
300
US
BIIB800, BAT1806, Actemra, Tocilizumab, RoActemra
Biogen
Healthy Volunteer
11/24
11/24
ChiCTR2300075487: A randomised, double-blind, single dose, parallel two-arm study of the pharmacokinetics and safety of BAT1806 subcutaneous injection versus ACTEMRA® in healthy male subjects in China

Not yet recruiting
1
150
 
BAT1806 subcutaneous injection group; ACTEMRA (EU) group
Drug Clinical Trial Research Center, The Second Affiliated Hospital of Anhui Medical University; Bio-Thera Solutions, Ltd., Bio-Thera Solutions, Ltd.
Rheumatoid arthritis
 
 
NCT06488521: A Safety and Pharmacokinetics Study of Complarate (Tocilizumab Biosimilar Solution) and Actemra® in Healthy Volunteers

Recruiting
1
256
RoW
Complarate, Tocilizumab biosimilar, Actemra®, Tocilizumab
AO GENERIUM
Healthy Volunteers
09/24
12/24
1B-22-2, NCT04616248: In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors

Recruiting
1
18
US
Anti-CD40 Agonist Monoclonal Antibody CDX-1140, Agonist CD40 Antibody CDX-1140, Anti-CD40 Agonistic Monoclonal Antibody CDX-1140, CDX 1140, CDX-1140, Poly ICLC, Hiltonol, Poly I:Poly C with Poly-L-Lysine Stabilizer, poly-ICLC, PolyI:PolyC with Poly-L-Lysine Stabilizer, Polyinosinic-Polycytidylic Acid Stabilized with Polylysine and Carboxymethylcellulose, Polyriboinosinic-Polyribocytidylic Acid-Polylysine Carboxymethylcellulose, Stabilized Polyriboinosinic/Polyribocytidylic Acid, Radiation Therapy, Cancer Radiotherapy, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation, Recombinant Flt3 Ligand, CDX-301, FLT 3 Ligand, FLT3 Ligand, Flt3-Ligand, Flt3L, Mobist, Mobista, rhuFlt3L, Pembrolizumab, Keytruda, Tocilizumab, Actemra
University of Southern California
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8, Unresectable Breast Carcinoma, Metastatic Melanoma, Unresectable Melanoma, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma, Soft Tissue Sarcoma, Bone Sarcoma, Sarcoma,Soft Tissue, Sarcoma of Bone, Basal Cell Carcinoma
01/25
01/26

Download Options